Log In
Print this Print this

Biosimilar cetuximab

  Manage Alerts
Collapse Summary General Information
Company Mabion S.A.
DescriptionBiosimilar of cetuximab, a chimeric IgG1 mAb targeting EGFR
Molecular Target Epidermal growth factor receptor (EGFR)
Mechanism of ActionBinds epidermal growth factor (EGF) receptor; Antibody; Biosimilar
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentDiscovery
Standard Indication Cancer (unspecified)
Indication DetailsTreat cancer
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today